Sign Up to like & get recommendations! 0
Published in 2020 at "Chinese Chemical Letters"
DOI: 10.1016/j.cclet.2020.03.017
Abstract: Abstract Sodium taurocholate cotransporting polypeptide (NTCP) is identified as the functional receptor for HBV entry, which is responsible for upregulated HBV transcription in the HBV life cycle. Besides, NTCP is also implicated in the progression… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Virology"
DOI: 10.1016/j.virol.2018.07.006
Abstract: Sodium taurocholate cotransporting polypeptide (NTCP) is a functional receptor for human hepatitis B virus (HBV) and its satellite virus Hepatitis D virus (HDV). Physiologically, NTCP is responsible for the majority of sodium-dependent bile acids uptake… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Oncotarget"
DOI: 10.18632/oncotarget.25348
Abstract: Sodium taurocholate cotransporting polypeptide (NTCP) is a major entry receptor of hepatitis B virus (HBV) and one of the most attractive targets for anti-HBV drugs. We developed a cell-mediated drug screening method to monitor NTCP… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Translational pediatrics"
DOI: 10.21037/tp-20-360
Abstract: Sodium-taurocholate cotransporting polypeptide (NTCP) deficiency is a newly reported hereditary bile acid metabolic disease. Here we describe the clinical characteristics of 12 cases of pediatric NTCP deficiency, as well as review 60 previously reported cases… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Genetics"
DOI: 10.3389/fgene.2022.874379
Abstract: Na+-taurocholate cotransporting polypeptide deficiency (NTCPD) is an autosomal recessive disorder arising from biallelic SLC10A1 mutations. As a newly-described inborn error of bile acid metabolism, the epidemiology of this condition remains largely unclear in Chinese population… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Frontiers in Microbiology"
DOI: 10.3389/fmicb.2022.920280
Abstract: One of the most desirable targets for HBV medications is the sodium taurocholate cotransporting polypeptide (NTCP), an entry receptor for the hepatitis B virus (HBV). N-myristoylated preS1 2–48 (Myrcludex B or Hepcludex), an NTCP-binding peptide… read more here.
Sign Up to like & get recommendations! 2
Published in 2023 at "Frontiers in Pharmacology"
DOI: 10.3389/fphar.2023.1147495
Abstract: The sodium taurocholate cotransporting polypeptide (NTCP; gene name SLC10A1) is the primary hepatic basolateral uptake transporter for conjugated bile acids and the entry receptor for the hepatitis B and D virus (HBV/HDV). Regulation of human… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10010196
Abstract: Hepatitis B virus (HBV) infections are among the major public health concerns worldwide with more than 250 million of chronically ill individuals. Many of them are additionally infected with the Hepatitis D virus, a satellite… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "International Journal of Molecular Sciences"
DOI: 10.3390/ijms23137468
Abstract: The hepatic Na+-taurocholate cotransporting polypeptide NTCP/SLC10A1 is important for the uptake of bile salts and selected drugs. Its inhibition results in increased systemic bile salt concentrations. NTCP is also the entry receptor for the hepatitis… read more here.
Sign Up to like & get recommendations! 0
Published in 2022 at "Journal of infection in developing countries"
DOI: 10.3855/jidc.15138
Abstract: INTRODUCTION Sodium taurocholate cotransporting polypeptide has been identified as the hepatitis B virus (HBV) entry receptor. However, information regarding the role of sodium taurocholate cotransporting polypeptide variants in the development of HBV-related advanced cirrhosis and… read more here.